Oracle Investment Management as of June 30, 2018
Portfolio Holdings for Oracle Investment Management
Oracle Investment Management holds 17 positions in its portfolio as reported in the June 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Quidel Corporation | 47.8 | $164M | 2.5M | 66.50 | |
| Pacific Biosciences of California (PACB) | 10.0 | $35M | 9.7M | 3.55 | |
| Tesaro | 10.0 | $34M | 775k | 44.47 | |
| Opko Health (OPK) | 5.0 | $17M | 3.7M | 4.70 | |
| Accelr8 Technology | 4.9 | $17M | 4.9M | 3.47 | |
| Adaptimmune Therapeutics (ADAP) | 4.8 | $17M | 1.4M | 11.87 | |
| Amarin Corporation (AMRN) | 4.7 | $16M | 5.3M | 3.09 | |
| Vermillion | 2.2 | $7.7M | 9.8M | 0.78 | |
| Biolase | 2.2 | $7.5M | 6.2M | 1.21 | |
| Contrafect | 2.1 | $7.1M | 3.2M | 2.21 | |
| Arena Pharmaceuticals | 1.8 | $6.1M | 140k | 43.60 | |
| Soleno Therapeutics | 1.7 | $5.7M | 2.4M | 2.34 | |
| Agenus (AGEN) | 1.0 | $3.4M | 1.5M | 2.27 | |
| Aduro Biotech | 0.6 | $2.1M | 297k | 7.00 | |
| Biogen Idec (BIIB) | 0.5 | $1.8M | 6.4k | 290.20 | |
| Epizyme | 0.5 | $1.7M | 127k | 13.55 | |
| Mazor Robotics Ltd. equities | 0.2 | $697k | 135k | 5.15 |
